A randomized, controlled, feasibility study of RD‐X19 in subjects with mild‐to‐moderate COVID‐19 in the outpatient setting-Reference-Cited by-同舟云学术

A randomized, controlled, feasibility study of RD‐X19 in subjects with mild‐to‐moderate COVID‐19 in the outpatient setting

Published:2022-02-27 Issue:5 Volume:15 Page:1291-1303
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Stasko Nathan¹,Cockrell Adam S.¹,Kocher Jacob F.¹,Henson Ibrahim¹,Emerson David¹,Wang Ye²,Smith Jonathan R.³,Henderson Nathan H.⁴,Wood Hillary⁴,Bradrick Shelton S.⁴,Jones Terry⁵,Santander Jorge⁶,McNeil John G.¹

Affiliation:

1. EmitBio Inc Durham North Carolina USA

2. Symbio, LLC Port Jefferson New York USA

3. Adaptive Plus, LLC Durham North Carolina USA

4. MRIGlobal Kansas City Missouri USA

5. J&S Studies, Inc College Station Texas USA

6. APF Research International, LLC Miami Florida USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13249

Reference33 articles.

1. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

2. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

3. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

4. SARS-CoV-2 infection of the oral cavity and saliva

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The inhibitory and inactivating effects of visible light on SARS-CoV-2: A narrative update;Journal of Photochemistry and Photobiology;2023-06

2. Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2;Journal of Dentistry;2022-08

3. Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19;Journal of Medical Economics;2022-04-09